NDC properties for NDC 9 0591-2925
NDC item 00591292530
NDC 9 | 0591-2925 |
---|---|
NDC 10 | 0591-2925-30 |
NDC Item | 00591292530 |
packaging | 30 PACKET in 1 CARTON (0591-2925-30) / 1.25 g in 1 PACKET (0591-2925-32) |
ANDA | ANDA204570 |
DCSA | CIII |
FDA SPL set id | 546325 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-02-12 |
Marketing status | ACTIVE |
NDC item 00591292532
NDC 9 | 0591-2925 |
---|---|
NDC 10 | 0591-2925-32 |
NDC Item | 00591292532 |
packaging | 1.25 g in 1 PACKET |
ANDA | ANDA204570 |
DCSA | CIII |
FDA SPL set id | 546325 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-02-12 |
Marketing status | ACTIVE |
NDC item 16714096801
NDC 9 | 16714-968 |
---|---|
NDC 10 | 16714-968-01 |
NDC Item | 16714096801 |
packaging | 1.25 g in 1 PACKET |
ANDA | ANDA205781 |
DCSA | CIII |
FDA SPL set id | 775662 |
Labeler | Northstar Rx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-11-06 |
Marketing status | ACTIVE |
NDC item 16714096802
NDC 9 | 16714-968 |
---|---|
NDC 10 | 16714-968-02 |
NDC Item | 16714096802 |
packaging | 30 PACKET in 1 CARTON (16714-968-02) / 1.25 g in 1 PACKET (16714-968-01) |
ANDA | ANDA205781 |
DCSA | CIII |
FDA SPL set id | 775662 |
Labeler | Northstar Rx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-11-06 |
Marketing status | ACTIVE |
NDC item 45802028103
NDC 9 | 45802-281 |
---|---|
NDC 10 | 45802-281-03 |
NDC Item | 45802028103 |
packaging | 1.25 g in 1 PACKET |
ANDA | ANDA205781 |
DCSA | CIII |
FDA SPL set id | 784981 |
Labeler | Padagis Israel Pharmaceuticals Ltd |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-06-27 |
Marketing status | ACTIVE |
NDC item 45802028139
NDC 9 | 45802-281 |
---|---|
NDC 10 | 45802-281-39 |
NDC Item | 45802028139 |
packaging | 30 PACKET in 1 CARTON (45802-281-39) / 1.25 g in 1 PACKET (45802-281-03) |
ANDA | ANDA205781 |
DCSA | CIII |
FDA SPL set id | 784981 |
Labeler | Padagis Israel Pharmaceuticals Ltd |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-06-27 |
Marketing status | ACTIVE |
NDC item 45802075403
NDC 9 | 45802-754 |
---|---|
NDC 10 | 45802-754-03 |
NDC Item | 45802075403 |
packaging | 1.25 g in 1 PACKET (45802-754-03) |
ANDA | ANDA204268 |
DCSA | CIII |
FDA SPL set id | 602017 |
Labeler | Padagis Israel Pharmaceuticals Ltd |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-10-12 |
Marketing status | ACTIVE |
NDC item 68382036212
NDC 9 | 68382-362 |
---|---|
NDC 10 | 68382-362-12 |
NDC Item | 68382036212 |
packaging | 1.25 g in 1 PACKET |
DCSA | CIII |
FDA SPL set id | 676429 |
Labeler | Zydus Pharmaceuticals (USA) Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2018-10-12 |
Marketing status | COMPLETED |
NDA_AUTHORIZED_GENERIC | NDA022309 |